This report presents a case of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man, including an analysis of the virulence of the P. aeruginosa isolated from the patient. The patient was successfully treated with intensive care and antibiotic treatment. This study analyzed the pathogenicity of the isolated strain both in vivo (using a mouse pneumonia model) and in vitro (using biofilm production), but could not explain how an otherwise healthy young man developed such severe community-acquired P. aeruginosa pneumonia. Although rare in community-acquired pneumonia, P. aeruginosa infection should be considered in patients with severe rapidly progressive pneumonia.
Introduction
Pseudomonas aeruginosa is a common cause of nosocomial respiratory tract, urinary tract, and bloodstream infections (1) . This species also is an important opportunistic pathogen, especially in the hospital setting, and the respiratory tract is the most frequent site of such infections (1) . The majority of hospitalized patients have an underlying medical condition or a risk factor for P. aeruginosa infection. The typical patient presenting with nosocomial P. aeruginosa infection is mechanically ventilated, has slowly progressive lung infiltrates, and has been colonized with P. aeruginosa for days (2) . Although rare, there have been some reports of community-acquired P. aeruginosa pneumonia in previously healthy individuals (3) (4) (5) (6) , for example, among individuals who have inhaled contaminated hot tub steam (5, 6) , and P. aeruginosa community-acquired pneumonia (CAP) presents as a rapidly progressive, sometimes fatal disease (3) (4) (5) (6) .
This report presents a case of a successfully treated fulminant community-acquired P. aeruginosa necrotizing pneumonia in a previously healthy 25-year-old man. In addition, also present the findings of an analysis of the virulence of the P. aeruginosa isolated from this patient, which was designated as the Kurashiki strain. He did not have family history. A physical examination showed his body temperature to be 37.5 , blood pressure was 119/68 mmHg, pulse was 97 beats per minute, oxygen saturation was 96% while breathing ambient air, and respiratory rate was 18 breaths per minute. Chest auscultation revealed no adventitious breath sounds. The cardiac findings were normal. The remainder of the physical examination was normal. A chest radiograph revealed no shadow in the lung fields (Fig. 1A) . The patient was prescribed a combination cold remedy and sent home.
The patient returned to the emergency room ten hours later with exacerbated right back pain, fever, chills, and a cough producing blood and rust-colored sputum. A physical examination showed that his body temperature was 38.9 , blood pressure was 88/59 mmHg, pulse was 113 beats per minute, oxygen saturation was 97% while breathing ambient air, and respiratory rate was 28 breaths per minute. Chest examination revealed decreased breath sounds in the right mid-lung field with dullness to percussion and egophony. A chest radiograph revealed a rapidly expanding shadow in the right upper lobe (Fig. 1B) . Laboratory examinations demonstrated elevated levels of C-reactive protein (14.07 mg/dL, normal <0.20 mg/dL), a white blood cell count of 7,800/μL with a left shift (89.2% neutrophils), and a platelet count of 82,000 cells/μL. Other data are shown in (Table) . Although thrombocytopenia was observed, there was no disseminated intravascular coagulation. The patient's consciousness deteriorated, and both blood pressure and oxygen saturation suddenly decreased. The patient was tentatively diagnosed with septic shock due to bacterial pneumonia (A-DROP score 3/ 5; respiratory failure, orientation and low blood pressure, CURB65 score 2/5; confusion and low blood pressure), and therefore was transferred to the intensive care unit following a massive infusion of lactated Ringer's solution, along with an empirical combination of ampicillin (2 g q6h) and levofloxacin (500 mg q24h). Pressor agents were administered, and a Swan-Ganz catheter was placed. Initial hemodynamic values were consistent with septic shock. Chest X-ray after Swan-Ganz catheter placement revealed progression of right lung infiltrates. Intubation was performed. Gram stains of tracheal secretions revealed >25 polymorphonuclear leukocytes and <10 epithelial cells, and a few gram positive cocci and few gram negative rods, and no microorganisms were engulfed. The results of sputum and tracheal secretion cultures performed by the microbiology laboratory on the third day of hospitalization confirmed the predominant presence of P. aeruginosa; the results of two blood culture sets collected at the same time were negative. The result of antibiotic sensitivity testing for the P. aeruginosa is shown in (Table) . The sample of tracheal secretion was re-evaluated and confirmed gram negative rods engulfed in the leukocytes (Fig. 2) . The patient's antimicrobial regimen was changed to meropenem (1 g q8h) and levofloxacin (500 mg q24h). The patient's condition gradually stabilized over the next few days and P. aeruginosa became undetectable in the expectorated sputum. He was extubated after 8 days of ventilator support, and transferred to a rehabilitation unit. The cultured P. aeruginosa exhibited susceptibility in vitro to both meropenem (MIC: 0.25 μg/mL) and levofloxacin (MIC: 0.25 μg/mL; MIC: minimal inhibitory concentration).
The patient was negative for human immunodeficiency virus (HIV) and human adult T cell leukemia virus-I (HTLV-I), and serum immunoglobulin and complement levels were normal; thus, the patient exhibited no indications of immunodeficiency. Additional questioning revealed that the patient had not been exposed to any potential sources of P. aeruginosa infection, including home humidifiers, home whirlpools, or hot tubs. The patient did not report any apparent workplace contact with elderly individuals presenting with productive cough or fever.
The patient improved clinically and was discharged 28 days after admission. A chest radiograph at discharge showed cavitation after resolution of the consolidation in the right upper lobe (Fig. 3A) and chest computed tomography showed a cavitating or necrotizing lesion in the right upper lobe (Fig. 3B) . The patient completed a 4-week course of antibiotics, and an outpatient follow-up visit 6 months after discharge revealed that the patient was healthy. A chest Xray obtained 6 months after discharge revealed the complete resolution of parenchymal infiltrates. 
Environmental investigation
The present patient had been working in a care facility for 3 years. His main job responsibilities were helping participants eat meals and acting as a host for recreational programs. Assisting the elderly in taking baths was a task assigned mainly to the female staff; the patient rarely entered the bathroom during work hours.
Nine water samples were obtained from the care facility, including one each from three washrooms in the hall, three toilets, a shower in the bathroom, and two rest rooms used by the staff. P. aeruginosa was detected at 100 colonyforming units (CFUs) per 100 mL in each of three specimens (from 2 washrooms and 1 bathroom). The remaining samples all were negative for P. aeruginosa. The three isolates were typed by pulsed-field gel electrophoresis (PFGE) performed by a method modified from the standard protocol (7). DNA was digested using the restriction enzyme SpeI (8) . A dendrogram, revealed isolates with a genetic relatedness of >80% that were considered to represent the same PFGE type (9) . The three isolates yielded PFGE patterns clearly distinguishable from that of the isolate (designated the Kurashiki strain) derived from the patient' tracheal secretions. Therefore, the three strains isolated from the care facility were considered to be unrelated to the Kurashiki strain.
The present patient might have been exposed to the pathogen at his house or in his neighborhood. Therefore, we asked him whether additional environmental investigations were permissible, but he declined the proposal. Unfortunately, no further environmental investigations could be conducted.
Mouse pneumonia model
The virulence of the Kurashiki strain was evaluated using a mouse pneumonia model (10). The P. aeruginosa PAO1 strain was used as a comparator; PAO1 is a laboratory reference strain originally isolated from an infected burn/wound of a patient in Melbourne, Australia (American Type Culture Collection ATCC15692), and was obtained as a gift from Barbara H. Iglewski, University of Rochester, Rochester, USA. C57BL/6J mice (female, 6 weeks old) were purchased from Charles River Japan (Kanagawa, Japan). Mice were housed in the animal care facility of Toho University. All animal experiments were performed with the approval of the animal center of Toho University (approval number #10-52-54). Each group of six mice was anaesthetized intramuscularly with 50 mg/kg ketamine and 10 mg/kg xylazine. A bacterial suspension (30 μL) was administered intranasally. The bacterial burden of the lungs was assessed 24 hours and 48 hours after the infection. Mice were sacrificed by CO2 asphyxia. Whole lungs were homogenized in 1 mL of sterile saline using a tissue homogenizer (IKA, Osaka, Japan). Homogenates (10 μL) were inoculated onto Muller-Hinton agar after serial 1:10 dilutions. Fig. 4A shows that no death was observed in the Kurashiki strain group and only a few mice in the PAO1 strain group died. A quantitative bacteriological examination in the lung was performed (Fig. 4B) , and no significant difference was observed in the bacterial count in the lung, although the bacterial number of the Kurashiki strain on day 2 was slightly larger than that of the PAO1 strain.
Biofilm production
The biofilm formation of P. aeruginosa was measured by using the method of Kimura et al. (11) . Overnight cultures of P. aeruginosa were resuspended in fresh Luria-Bertani broth in 96-well tissue culture plates (Becton Dickinson, NJ, USA). The plates were incubated at 35 for 3 days, and the biofilms on the plates were stained with 0.3% crystal violet solution. The plates were rinsed to remove planktonic cells, and the biofilm was then quantified by solubilizing the dye in ethanol and measuring the absorbance at 595 nm. The values presented are the results of six replicate experiments. Fig. 5 shows the biofilm formation activity of the Kurashiki strain to be significantly inferior to the PAO1 strain.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 5 software package (GraphPad, Inc., CA, USA). All data are presented as the means ± SD. Significance was tested by the Kaplan-Meier and t-test. A p value <0.05 was considered to be statistically significant.
Discussion
Recent observational studies have shown P. aeruginosa to be a rare cause of CAP and the etiologic microbe in 1% to 5% of patients with CAP (12) (13) (14) (15) . On the other hand, P. aeruginosa has been reported to be the cause of severe CAP (CAP necessitating admission to the ICU or causing shock) in 1.8% to 8.3% of patients, with a case-fatality rate of 50% to 100% (16) (17) (18) (19) . Although the classic features of pneumonia due to P. aeruginosa are its occurrence in compromised hosts and in lung-disease patients with hemorrhagic and necrotizing lung pathology, there have been case reports of previously healthy individuals with CAP caused by P. aeruginosa (3) (4) (5) (6) . Such cases are often rapidly progressive and fatal, with morbidity rates exceeding 30% (3). Some cases were attributable to an identifiable source, such as a home humidifier or a home whirlpool spa (5, 6) . Occupational exposure also may be a risk factor for P. aeruginosa pneumonia. Cirigliano and Grippi published a case report of P. aeruginosa pneumonia in a previously healthy nursing assistant (4). However, most cases had no identifiable environmental source of infection (1, 3). An environmental investigation was conducted in the current case, including a survey of possible water sources in the patient's workplace. While three separate strains were detected in the nine water samples that were tested, all three were distinct from the patient-derived isolate by PFGE analysis.
The present patient had no previous medical history and had been healthy until admission. He had a 2.5 pack-year smoking history, but he was a non-immunocompromised host and had no known risk factors for P. aeruginosa infection. Smoking substantially increases the risk of invasive pneumococcal disease and has substantial local and systemic effects on the respiratory tract and the immune system (20) . Although results from studies of the impact of smoking on the outcome of invasive pneumonia are controversial (21) , broad-spectrum antibiotics should have been considered as the first-line treatment for the severe community-acquired pneumonia in the present case because of his current smoking history.
Therefore, the pathogenicity of the patient's isolate (which we designated the Kurashiki strain) was analysed by both in vivo (a mouse pneumonia model) and in vitro (biofilm production) assays. Notably, the Kurashiki-infected animals did not exhibit mortality, in contrast to the fatalities observed among the PAO1-inoculated mice. Moreover, biofilm formation by the Kurashiki strain was significantly reduced in comparison to that of PAO1. Biofilm formation capacity independently contributes to the virulence of Panton-Valentine leukocidin (PVL)-positive communityacquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection, and is related to the pathogenesis of necrotizing pneumonia (22) . These data suggest that the Kurashiki strain is not more virulent than the PAO1 strain. The current analyses do not explain why a healthy young man developed such a severe case of community-acquired P. aeruginosa pneumonia. However, it remains possible that the Kurashiki strain harbours other untested and/or novel bacterial virulence factors (Elastase, Alkaline protease, Pyocyanin…etc.) (23) that are associated with the development of this disease.
Mortality in hospitalized CAP patients depends on multiple factors, including age, comorbidities, microbial etiology, and early and adequate antibiotic treatment. Although there have been no randomized clinical trials of the treatment of P. aeruginosa pneumonia, the adequacy of the initial antibiotic treatment is the only factor amenable to modification by medical intervention and as a consequence, the initial antibiotic treatment is frequently administered on an empirical basis (24) . Therefore, most of the current guidelines for CAP include recommendations to suspect and empirically treat P. aeruginosa (25) . Ampicillin and levofloxacin were chosen as the initial empirical antibiotic treatment in the current case. The antibiotic treatment was changed to meropenem and levofloxacin after P. aeruginosa had been cultured from this patient's sputum and tracheal secretions. This P. aeruginosa strain was highly susceptible to both meropenem and levofloxacin. It is possible that the crucial element in the success of treating this patient was the early administration of antibiotics efficacious for P. aeruginosa.
Hatchette et al. (3) reviewed 11 case reports of P. aeruginosa CAP in previously healthy adults and reported that two-thirds of these patients experienced involvement of the right upper lobe. The present case also showed a rapid progressive consolidation beginning with the right upper lobe. Why P. aeruginosa CAP has a tendency to begin with the right upper lobe is unclear. A future study will accumulate similar cases and examine this phenomenon.
Although rare, P. aeruginosa CAP is often rapidly progressive and can occur in previously healthy patients with relative high mortality rate. Even if there is no apparent risk factor, such as exposure to aerosols of contaminated water or occupational exposure to a P. aeruginosa carrier, P. aeruginosa must be considered in the differential diagnosis in any patient presenting with severe rapidly progressive CAP. Treatment should include combination therapy with anti-Pseudomonas agents to prevent the emergence of resistance and to save the patient's life.
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